Annual Net Income
-$29.82 M
+$12.54 M+29.60%
31 December 2023
Summary:
Achieve Life Sciences annual net profit is currently -$29.82 million, with the most recent change of +$12.54 million (+29.60%) on 31 December 2023. During the last 3 years, it has fallen by -$15.09 million (-102.41%). ACHV annual net income is now -1853.82% below its all-time high of $1.70 million, reached on 31 December 1996.ACHV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$12.51 M
-$4.05 M-47.88%
30 September 2024
Summary:
Achieve Life Sciences quarterly net profit is currently -$12.51 million, with the most recent change of -$4.05 million (-47.88%) on 30 September 2024. Over the past year, it has dropped by -$5.40 million (-76.03%). ACHV quarterly net income is now -195.86% below its all-time high of $13.05 million, reached on 31 December 2016.ACHV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$32.94 M
-$5.40 M-19.62%
30 September 2024
Summary:
Achieve Life Sciences TTM net profit is currently -$32.94 million, with the most recent change of -$5.40 million (-19.62%) on 30 September 2024. Over the past year, it has increased by +$2.63 million (+7.39%). ACHV TTM net income is now -466.40% below its all-time high of $8.99 million, reached on 30 June 2017.ACHV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.6% | -76.0% | +7.4% |
| 3 y3 years | -102.4% | -87.0% | -7.2% |
| 5 y5 years | -135.0% | -240.7% | -95.7% |
ACHV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -102.4% | +29.6% | -128.5% | +4.3% | -20.6% | +24.7% |
| 5 y | 5 years | -135.0% | +29.6% | -328.2% | +4.3% | -151.3% | +24.7% |
| alltime | all time | -1853.8% | +29.6% | -195.9% | +4.3% | -466.4% | +24.7% |
Achieve Life Sciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.51 M(+47.9%) | -$32.94 M(+19.6%) |
| June 2024 | - | -$8.46 M(+30.3%) | -$27.54 M(+0.8%) |
| Mar 2024 | - | -$6.49 M(+18.6%) | -$27.32 M(-8.4%) |
| Dec 2023 | -$29.82 M(-29.6%) | -$5.48 M(-23.0%) | -$29.82 M(-16.2%) |
| Sept 2023 | - | -$7.11 M(-13.7%) | -$35.57 M(-14.4%) |
| June 2023 | - | -$8.24 M(-8.4%) | -$41.54 M(-5.1%) |
| Mar 2023 | - | -$8.99 M(-19.9%) | -$43.77 M(+3.4%) |
| Dec 2022 | -$42.35 M(+27.7%) | -$11.23 M(-14.1%) | -$42.35 M(+10.7%) |
| Sept 2022 | - | -$13.08 M(+24.9%) | -$38.27 M(+20.0%) |
| June 2022 | - | -$10.47 M(+38.2%) | -$31.88 M(-2.6%) |
| Mar 2022 | - | -$7.57 M(+5.9%) | -$32.73 M(-1.3%) |
| Dec 2021 | -$33.15 M(+125.1%) | -$7.15 M(+6.9%) | -$33.15 M(+7.9%) |
| Sept 2021 | - | -$6.69 M(-40.8%) | -$30.73 M(+10.5%) |
| June 2021 | - | -$11.31 M(+41.4%) | -$27.80 M(+43.2%) |
| Mar 2021 | - | -$8.00 M(+69.3%) | -$19.41 M(+31.8%) |
| Dec 2020 | -$14.73 M(-10.2%) | -$4.72 M(+25.5%) | -$14.73 M(+11.6%) |
| Sept 2020 | - | -$3.76 M(+28.8%) | -$13.20 M(+0.7%) |
| June 2020 | - | -$2.92 M(-12.0%) | -$13.11 M(-5.1%) |
| Mar 2020 | - | -$3.32 M(+3.9%) | -$13.81 M(-15.8%) |
| Dec 2019 | -$16.39 M(+29.2%) | -$3.19 M(-13.0%) | -$16.39 M(-2.6%) |
| Sept 2019 | - | -$3.67 M(+1.4%) | -$16.84 M(+2.6%) |
| June 2019 | - | -$3.62 M(-38.6%) | -$16.41 M(+5.4%) |
| Mar 2019 | - | -$5.90 M(+62.3%) | -$15.57 M(+22.7%) |
| Dec 2018 | -$12.69 M(+19.9%) | -$3.64 M(+12.3%) | -$12.69 M(-0.8%) |
| Sept 2018 | - | -$3.24 M(+16.2%) | -$12.79 M(-20.2%) |
| June 2018 | - | -$2.79 M(-7.7%) | -$16.02 M(+19.6%) |
| Mar 2018 | - | -$3.02 M(-19.2%) | -$13.40 M(+26.6%) |
| Dec 2017 | -$10.58 M(+757.6%) | -$3.74 M(-42.2%) | -$10.58 M(-270.4%) |
| Sept 2017 | - | -$6.47 M(+3798.8%) | $6.21 M(-30.9%) |
| June 2017 | - | -$166.00 K(-19.0%) | $8.99 M(+296.4%) |
| Mar 2017 | - | -$205.00 K(-101.6%) | $2.27 M(-283.8%) |
| Dec 2016 | -$1.23 M(-92.7%) | $13.05 M(-453.7%) | -$1.23 M(-92.3%) |
| Sept 2016 | - | -$3.69 M(-46.4%) | -$16.01 M(-5.1%) |
| June 2016 | - | -$6.89 M(+85.8%) | -$16.87 M(+5.5%) |
| Mar 2016 | - | -$3.71 M(+115.0%) | -$15.99 M(-4.8%) |
| Dec 2015 | -$16.80 M(-36.0%) | -$1.72 M(-62.1%) | -$16.80 M(-19.1%) |
| Sept 2015 | - | -$4.55 M(-24.3%) | -$20.76 M(-1.7%) |
| June 2015 | - | -$6.01 M(+33.1%) | -$21.11 M(-4.5%) |
| Mar 2015 | - | -$4.52 M(-20.5%) | -$22.12 M(-15.7%) |
| Dec 2014 | -$26.24 M(-17.6%) | -$5.68 M(+15.8%) | -$26.24 M(-3.7%) |
| Sept 2014 | - | -$4.91 M(-30.0%) | -$27.24 M(-15.9%) |
| June 2014 | - | -$7.01 M(-18.8%) | -$32.38 M(-4.2%) |
| Mar 2014 | - | -$8.64 M(+29.3%) | -$33.79 M(+6.1%) |
| Dec 2013 | -$31.85 M(+51.0%) | -$6.68 M(-33.6%) | -$31.85 M(+8.8%) |
| Sept 2013 | - | -$10.05 M(+19.4%) | -$29.27 M(+16.4%) |
| June 2013 | - | -$8.42 M(+25.7%) | -$25.14 M(+20.1%) |
| Mar 2013 | - | -$6.70 M(+63.2%) | -$20.93 M(-0.8%) |
| Dec 2012 | -$21.10 M(+43.8%) | -$4.10 M(-30.7%) | -$21.10 M(-20.6%) |
| Sept 2012 | - | -$5.92 M(+40.5%) | -$26.56 M(+64.2%) |
| June 2012 | - | -$4.21 M(-38.6%) | -$16.17 M(-12.5%) |
| Mar 2012 | - | -$6.86 M(-28.3%) | -$18.49 M(+26.0%) |
| Dec 2011 | -$14.67 M(+16.6%) | -$9.57 M(-314.1%) | -$14.67 M(+85.6%) |
| Sept 2011 | - | $4.47 M(-168.5%) | -$7.91 M(-59.0%) |
| June 2011 | - | -$6.53 M(+114.4%) | -$19.27 M(+53.1%) |
| Mar 2011 | - | -$3.04 M(+8.8%) | -$12.59 M(+0.0%) |
| Dec 2010 | -$12.58 M(+129.8%) | -$2.80 M(-59.4%) | -$12.58 M(+113.2%) |
| Sept 2010 | - | -$6.89 M(-4576.6%) | -$5.90 M(+323.5%) |
| June 2010 | - | $154.00 K(-105.1%) | -$1.39 M(-77.2%) |
| Mar 2010 | - | -$3.04 M(-178.4%) | -$6.11 M(+11.6%) |
| Dec 2009 | -$5.48 M | $3.88 M(-262.7%) | -$5.48 M(-61.7%) |
| Sept 2009 | - | -$2.38 M(-47.7%) | -$14.31 M(+94.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | -$4.56 M(+89.4%) | -$7.35 M(+11.5%) |
| Mar 2009 | - | -$2.41 M(-51.4%) | -$6.59 M(-20.6%) |
| Dec 2008 | -$4.20 M(-67.8%) | -$4.96 M(-208.3%) | -$8.30 M(+487.9%) |
| Sept 2008 | - | $4.58 M(-220.2%) | -$1.41 M(-88.0%) |
| June 2008 | - | -$3.81 M(-7.5%) | -$11.80 M(-15.5%) |
| Mar 2008 | - | -$4.12 M(-312.9%) | -$13.95 M(+6.8%) |
| Dec 2007 | -$13.06 M(-44.5%) | $1.93 M(-133.3%) | -$13.06 M(-40.6%) |
| Sept 2007 | - | -$5.81 M(-2.6%) | -$22.01 M(-2.2%) |
| June 2007 | - | -$5.96 M(+84.9%) | -$22.49 M(+4.8%) |
| Mar 2007 | - | -$3.23 M(-54.0%) | -$21.47 M(-8.9%) |
| Dec 2006 | -$23.55 M(+11.6%) | -$7.01 M(+11.4%) | -$23.55 M(+18.6%) |
| Sept 2006 | - | -$6.29 M(+27.5%) | -$19.86 M(-11.6%) |
| June 2006 | - | -$4.94 M(-7.1%) | -$22.48 M(+3.9%) |
| Mar 2006 | - | -$5.31 M(+59.8%) | -$21.63 M(+2.5%) |
| Dec 2005 | -$21.10 M(+29.3%) | -$3.32 M(-62.7%) | -$21.10 M(-8.8%) |
| Sept 2005 | - | -$8.91 M(+117.8%) | -$23.13 M(+29.7%) |
| June 2005 | - | -$4.09 M(-14.3%) | -$17.84 M(+1.9%) |
| Mar 2005 | - | -$4.78 M(-10.9%) | -$17.51 M(+7.3%) |
| Dec 2004 | -$16.31 M(+55.8%) | -$5.36 M(+48.3%) | -$16.31 M(+20.3%) |
| Sept 2004 | - | -$3.61 M(-4.0%) | -$13.56 M(+8.9%) |
| June 2004 | - | -$3.76 M(+5.1%) | -$12.45 M(+5.7%) |
| Mar 2004 | - | -$3.58 M(+37.3%) | -$11.77 M(+12.5%) |
| Dec 2003 | -$10.47 M(-10.0%) | -$2.61 M(+4.2%) | -$10.47 M(+1.9%) |
| Sept 2003 | - | -$2.50 M(-19.0%) | -$10.27 M(-7.0%) |
| June 2003 | - | -$3.09 M(+35.7%) | -$11.04 M(-4.0%) |
| Mar 2003 | - | -$2.27 M(-5.6%) | -$11.50 M(-1.2%) |
| Dec 2002 | -$11.64 M(-2246.0%) | -$2.41 M(-26.3%) | -$11.64 M(+2.4%) |
| Sept 2002 | - | -$3.27 M(-7.7%) | -$11.36 M(+287.1%) |
| June 2002 | - | -$3.54 M(+46.8%) | -$2.93 M(+158.8%) |
| Mar 2002 | - | -$2.41 M(+13.3%) | -$1.13 M(-309.1%) |
| Dec 2001 | $542.20 K(-125.2%) | -$2.13 M(-141.3%) | $542.20 K(-80.5%) |
| Sept 2001 | - | $5.15 M(-395.7%) | $2.79 M(-161.5%) |
| June 2001 | - | -$1.74 M(+136.3%) | -$4.53 M(+516.6%) |
| Mar 2001 | - | -$737.60 K(-752.2%) | -$735.30 K(-65.8%) |
| Dec 2000 | -$2.15 M(-594.0%) | $113.10 K(-105.2%) | -$2.15 M(-49.3%) |
| Sept 2000 | - | -$2.17 M(-205.4%) | -$4.23 M(-187.4%) |
| June 2000 | - | $2.06 M(-195.6%) | $4.84 M(-1657.7%) |
| Mar 2000 | - | -$2.15 M(+8.9%) | -$311.00 K(-170.9%) |
| Dec 1999 | $434.70 K(-103.9%) | -$1.97 M(-128.6%) | $438.70 K(-221.5%) |
| Sept 1999 | - | $6.91 M(-323.0%) | -$361.00 K(-96.1%) |
| June 1999 | - | -$3.10 M(+121.4%) | -$9.27 M(0.0%) |
| Mar 1999 | - | -$1.40 M(-49.5%) | -$9.27 M(-17.0%) |
| Dec 1998 | -$11.17 M(-1217.3%) | -$2.77 M(+38.7%) | -$11.17 M(+39.7%) |
| Sept 1998 | - | -$2.00 M(-35.5%) | -$8.00 M(+12.7%) |
| June 1998 | - | -$3.10 M(-6.1%) | -$7.10 M(+97.2%) |
| Mar 1998 | - | -$3.30 M(-925.0%) | -$3.60 M(-427.3%) |
| Dec 1997 | $1.00 M(-41.2%) | $400.00 K(-136.4%) | $1.10 M(-66.7%) |
| Sept 1997 | - | -$1.10 M(-375.0%) | $3.30 M(-54.2%) |
| June 1997 | - | $400.00 K(-71.4%) | $7.20 M(-7.7%) |
| Mar 1997 | - | $1.40 M(-46.2%) | $7.80 M(+358.8%) |
| Dec 1996 | $1.70 M(-128.8%) | $2.60 M(-7.1%) | $1.70 M(-142.5%) |
| Sept 1996 | - | $2.80 M(+180.0%) | -$4.00 M(-54.0%) |
| June 1996 | - | $1.00 M(-121.3%) | -$8.70 M(-14.7%) |
| Mar 1996 | - | -$4.70 M(+51.6%) | -$10.20 M(+72.9%) |
| Dec 1995 | -$5.90 M(-33.7%) | -$3.10 M(+63.2%) | -$5.90 M(+22.9%) |
| Sept 1995 | - | -$1.90 M(+280.0%) | -$4.80 M(-2.0%) |
| June 1995 | - | -$500.00 K(+25.0%) | -$4.90 M(-29.0%) |
| Mar 1995 | - | -$400.00 K(-80.0%) | -$6.90 M(-23.3%) |
| Dec 1994 | -$8.90 M | -$2.00 M(0.0%) | -$9.00 M(+28.6%) |
| Sept 1994 | - | -$2.00 M(-20.0%) | -$7.00 M(+40.0%) |
| June 1994 | - | -$2.50 M(0.0%) | -$5.00 M(+100.0%) |
| Mar 1994 | - | -$2.50 M | -$2.50 M |
FAQ
- What is Achieve Life Sciences annual net profit?
- What is the all time high annual net income for Achieve Life Sciences?
- What is Achieve Life Sciences annual net income year-on-year change?
- What is Achieve Life Sciences quarterly net profit?
- What is the all time high quarterly net income for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly net income year-on-year change?
- What is Achieve Life Sciences TTM net profit?
- What is the all time high TTM net income for Achieve Life Sciences?
- What is Achieve Life Sciences TTM net income year-on-year change?
What is Achieve Life Sciences annual net profit?
The current annual net income of ACHV is -$29.82 M
What is the all time high annual net income for Achieve Life Sciences?
Achieve Life Sciences all-time high annual net profit is $1.70 M
What is Achieve Life Sciences annual net income year-on-year change?
Over the past year, ACHV annual net profit has changed by +$12.54 M (+29.60%)
What is Achieve Life Sciences quarterly net profit?
The current quarterly net income of ACHV is -$12.51 M
What is the all time high quarterly net income for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly net profit is $13.05 M
What is Achieve Life Sciences quarterly net income year-on-year change?
Over the past year, ACHV quarterly net profit has changed by -$5.40 M (-76.03%)
What is Achieve Life Sciences TTM net profit?
The current TTM net income of ACHV is -$32.94 M
What is the all time high TTM net income for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM net profit is $8.99 M
What is Achieve Life Sciences TTM net income year-on-year change?
Over the past year, ACHV TTM net profit has changed by +$2.63 M (+7.39%)